Nasdaq plans to delist Windtree Therapeutics for violating minimum bid price rules. Windtree struggles with financial instability, possibly linked to its BNB investments.
Continue Reading:Windtree Faces Delisting as Nasdaq Tightens its Rules
The post Windtree Faces Delisting as Nasdaq Tightens its Rules appeared first on COINTURK NEWS.